Open, Single-arm, Multicenter, Phase II Trial Investigating the Safety of Biweekly Cabazitaxel in Metastatic Castration Resistant Prostate Cancer Patients Previously Treated With a Docetaxel-containing Regimen.

Trial Profile

Open, Single-arm, Multicenter, Phase II Trial Investigating the Safety of Biweekly Cabazitaxel in Metastatic Castration Resistant Prostate Cancer Patients Previously Treated With a Docetaxel-containing Regimen.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Cabazitaxel (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Acronyms ProstyII
  • Most Recent Events

    • 07 Jun 2016 Status changed from recruiting to completed as results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 31 Mar 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2011-003156-39).
    • 26 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top